Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pulse rhythm01:30

Pulse rhythm

814
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
814
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

17
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
17
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Consecutive Emergency Carotid Artery Stenting and Transcatheter Aortic Valve Replacement in a Patient With Cardiogenic Shock: A Case Report.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Removal of tine-based leadless pacemakers - Insights from a large multicenter experience.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

[Cardiovascular diseases and heart failure in diabetes: diagnostics and management (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

The prospective Austrian hypertrophic cardiomyopathy registry - design, methods and results of the run-in period.

Heart failure reviews·2026
Same author

Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry.

European heart journal·2026
Same author

Sex-specific short- and long-term outcomes in patients with leadless cardiac pacemakers.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

相关实验视频

Updated: Jul 12, 2025

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

2.6K

[无起器:一种"永久"的好解决方案?]

Clemens Steinwender1,2, Hermann Blessberger3, Karim Saleh3

  • 1Klinik für Kardiologie und Internistische Intensivmedizin, Kepler Universitätsklinikum Linz, Medizinische Fakultät, Johannes Kepler Universität Linz, Linz, Österreich. clemens.steinwender@kepleruniklinikum.at.

Herzschrittmachertherapie & Elektrophysiologie
|October 23, 2023
PubMed
概括

与传统起器相比,无起器是安全有效的,提供较少的长期并发症,如感染和问题. 这些设备代表了适合患者的持久解决方案.

关键词:
复杂性 复杂性 复杂性感染 感染 感染长期的结果 长期的结果植入心脏起器植入心脏起器降低风险 降低风险

更多相关视频

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.6K

相关实验视频

Last Updated: Jul 12, 2025

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

2.6K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.6K

科学领域:

  • 心脏病学 心脏病学
  • 医疗器械 医疗器械
  • 生物医学工程 生物医学工程

背景情况:

  • 传统的起器有相关的长期并发症,包括位和感染.
  • 无心脏起器技术为减轻这些风险提供了一个潜在的替代方案.

研究的目的:

  • 评估无心脏起器的长期安全性和有效性.
  • 为了比较无心脏起器系统与传统心脏起器系统的并发症率.

主要方法:

  • 对无心脏起器的批准研究和现实世界注册的审查.
  • 对并发症数据的分析,重点关注位和全身感染.

主要成果:

  • 目前可用的无心脏起器显示出高效率和安全性.
  • 与传统的起器系统相比,观察到较低的长期并发症率.
  • 证据,特别是MicraTM设备的证据,支持随着时间的推移持续的优势.

结论:

  • 无心脏起器是一个高效和安全的长期解决方案.
  • 与传统系统相比,它们具有显著的优势,特别是在减少与有关的并发症方面.
  • 适当的患者选择和植入是实现无步行全效益的关键.